Cytokinetics Communications Grant Program

The Cytokinetics Communications Grant Program is an annual grant program that provides funding to patient advocacy organizations serving hypertrophic cardiomyopathy, or HCM, and heart failure communities. The program is intended to help eligible organizations expand their reach, increase awareness, and strengthen engagement with patient communities through communications and outreach initiatives. Cytokinetics describes the funding as a resource for new or crucial communications initiatives that organizations might otherwise find challenging to implement. The 2027 application cycle opens September 14, 2026, and applications are due October 2, 2026, at 5:00 PM Pacific. Grant funding supports marketing and communications programming activities based on the needs of each organization. Proposed initiatives may take different forms and have different types or levels of impact. The selection criteria emphasize communications activities that expand the reach of organizational resources to patient communities, reach underserved communities or populations, build awareness of disease and associated symptoms and potential treatments, elevate patient voices with key stakeholders, and increase engagement with patients and caregivers. The source materials do not specify an award minimum, award maximum, total amount available through the program, a quantified number of awards, or a required matching or cost-sharing contribution. Eligible applicants must have nonprofit or registered charity status in the United States, Canada, Europe, or the United Kingdom and must serve patient communities in HCM or heart failure. Applicants are subject to Cytokinetics' standard due diligence review as well as applicable anti-bribery and anti-corruption review. The provided materials do not identify additional requirements concerning organizational size, operating history, fiscal sponsorship, faith-based status, or specific nonprofit tax classifications. They also do not provide separate state, province, or subnational geographic restrictions within the stated eligible countries and regions. Organizations applying for a Communications Grant are required to submit a proposal describing the activities the grant would support and the potential impact of the requested funding. Full application instructions are provided through the application portal. An organization that does not already have an account in Cytokinetics' system must establish an account in order to apply. The provided materials do not identify a letter of intent, concept paper, pre-proposal, notice of intent, or other pre-application gating requirement. Questions regarding the program or application process may be directed to grants@cytokinetics.com. Applications are evaluated by a committee of Cytokinetics representatives based on alignment with the program's selection criteria. Reach considerations include expanding organizational resources to the patient community through such approaches as reaching new constituents, deepening existing relationships or networks, creating partnerships, strengthening existing programs for wider or different audiences, and reaching underserved communities or populations. Awareness considerations include building awareness of disease, symptoms, potential treatments, and related topics and increasing or elevating the patient voice with key stakeholders by amplifying patient and caregiver stories and experiences. Community engagement focuses on increasing engagement with patient and caregiver communities through new or strengthened methods of connection. Impact is also an explicit evaluation category. Applicants are guided to include key performance indicators and measurable outcomes and to explain feasible methods for measuring success. The selection criteria also prompt applicants to consider whether the requested funding could help attract other funding for the proposed project. Grant recipients are responsible for providing an outcomes report to Cytokinetics at the end of the funding period so that impact can be measured. The provided materials do not specify the award notification date, grant start date, length of the funding period, or other performance-period dates. The program is described as awarding grants each year, establishing an annual recurrence. For the 2027 cycle, applications open September 14, 2026, and close October 2, 2026, at 5:00 PM Pacific. Based on the stated annual schedule, the next cycle after the currently announced cycle is tracked for September 2027. Applicants should consult the full instructions in the application portal for application requirements beyond those included in the supplied materials and may contact grants@cytokinetics.com with questions.

Demonstrate how the initiative expands organizational reach, including reach to underserved communities or populations; show how it builds disease awareness or elevates patient and caregiver voices; explain how it increases patient or caregiver engagement; include KPIs, measurable outcomes, and feasible methods for measuring success; consider whether the funding could help attract additional funding for the proposed project.